login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ABBVIE INC (ABBV) Stock News
USA
-
New York Stock Exchange
- NYSE:ABBV -
US00287Y1091
-
Common Stock
223.32
USD
-0.66 (-0.29%)
Last: 12/12/2025, 8:12:40 PM
222.5
USD
-0.82 (-0.37%)
After Hours:
12/12/2025, 8:12:40 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ABBV Latest News, Press Relases and Analysis
All
Press Releases
17 days ago - By: Chartmill
- Mentions:
NEM
APP
DE
IPG
...
Exploring the top movers within the S&P500 index during today's session.
2 hours ago - By: The Motley Fool
- Mentions:
LLY
ISRG
My Top 3 Healthcare Stocks to Buy in 2026
a day ago - By: The Motley Fool
- Mentions:
MRK
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
4 days ago - By: Zacks Investment Research
- Mentions:
BMY
JNJ
PFE
MRK
...
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal
5 days ago - By: Zacks Investment Research
AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know
5 days ago - By: Zacks Investment Research
- Mentions:
JPM
AAPL
MSFT
V
...
Top-Ranked ETFs to Power Your Portfolio Higher
9 days ago - By: Zacks Investment Research
- Mentions:
PFE
Pfizer (PFE) Up 3.9% Since Last Earnings Report: Can It Continue?
9 days ago - By: Zacks Investment Research
- Mentions:
JNJ
LLY
How Strong Is AbbVie's Immunology Franchise After Humira's LOE?
10 days ago - By: Zacks Investment Research
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
11 days ago - By: AbbVie Inc.
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
12 days ago - By: AbbVie
À l'occasion du 19e Congrès européen sur les céphalées, AbbVie va présenter les données de la phase 3 d'ECLIPSE démontrant la supériorité de l'atogépant (AQUIPTA®) par rapport au placebo dans le soulagement complet de la douleur pour le traitement aigu de
12 days ago - By: AbbVie
AbbVie präsentiert auf dem 19. European Headache Congress Phase-3-Daten aus der ECLIPSE-Studie, die die Überlegenheit von Atogepant (AQUIPTA®) gegenüber Placebo bei der Schmerzlinderung in der Akutbehandlung von Migräne belegen
12 days ago - By: AbbVie
AbbVie presentará datos de fase 3 de ECLIPSE en el 19º Congreso Europeo de Cefaleas
13 days ago - By: AbbVie
AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA®) Superiority Over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine at the 19th European Headache Congress
15 days ago - By: AbbVie Canada
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
15 days ago - By: AbbVie Canada
L’Agence des médicaments du Canada émet une recommandation positive pour le remboursement de SKYRIZI® (risankizumab) pour le traitement de la colite ulcéreuse, et AbbVie conclut une lettre d’intention avec l’Alliance pharmaceutique pancanadienne
16 days ago - By: Zacks Investment Research
- Mentions:
IRWD
PBYI
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?
17 days ago - By: Stocktwits
- Mentions:
LABU
NVO
TEVA
AZN
...
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared
17 days ago - By: Zacks Investment Research
- Mentions:
PFE
NVO
LLY
AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights
18 days ago - By: AbbVie Canada
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
18 days ago - By: AbbVie Canada
Lancement du Prix AbbVie des innovateurs en biotechnologies au Québec : AbbVie et adMare BioInnovations encouragent l’innovation dans le domaine des sciences de la vie
19 days ago - By: AbbVie
AbbVie to Present at the Piper Sandler 37th Annual Healthcare Conference
19 days ago - By: Zacks Investment Research
- Mentions:
JPM
NFLX
OVBC
The Zacks Analyst Blog JPMorgan, Netflix, AbbVie and Ohio Valley Banc
Please enable JavaScript to continue using this application.